GLP-3
Price range: $140.00 through $330.00
GLP-3 is a lab-tested triple incretin agonist research peptide targeting GLP-1, GIP, and glucagon receptor pathways. Available in 10mg to 50mg lyophilized vials. Purity: >99% verified by third-party HPLC testing. USA domestic fulfillment. For research use only. Not for human consumption.
Free shipping on orders over $149!
- 99% Purity (HPLC-MS Verified)
- Independent Third-Party Tested
- USA GMP Manufactured
- Complimentary BAC Water
- Ships in 24 Hours (USA)
Disclaimer: This product is intended solely for laboratory research purposes. It is not for human consumption, medical use, veterinary use, or household application. All product information on this website is provided for educational purposes only. Researchers must handle this product with appropriate safety protocols and comply with all applicable regulations. Please review our Terms & Conditions before purchasing.
GLP-3 Peptide Summary
GLP-3 is a synthetic research peptide engineered for laboratory use to study how multiple gut-hormone signals interact within metabolic models. As an advanced multi-receptor, incretin-style compound, it is utilized in controlled in vitro and preclinical study designs to examine energy balance pathways, appetite signaling, and metabolic biomarker shifts.
This peptide is primarily investigated in research settings focusing on how combined receptor agonism differs from single-pathway incretin models.
Peptide type: single peptide, engineered “multi-receptor” incretin-style research tool.
Vial options: 10mg to 50mg (lyophilized powder). Including 10mg, 15mg, 20mg, 24mg, 30mg, 40mg, and 50mg.
Primary research focus: energy balance and metabolism models, appetite and intake signaling models.
GLP-3 Product Specifications
| Property | Details |
|---|---|
| Product Contents | 10mg – 50mg Lyophilized Powder |
| Available Vial Sizes | 10mg, 15mg, 20mg, 24mg, 30mg, 40mg, and 50mg |
| Purity / Concentration | 99% (HPLC-Verified & Third-Party Tested) |
| Appearance | Solid, white powder in sterile glass vial |
| Peptide Type | Engineered multi-receptor incretin-style agonist |
| Research Application | Energy balance, metabolism models, and intake signaling |
| Storage Guidelines | Store at ≤6°C, sealed, away from heat, light, and moisture |
Lyophilized Peptides
These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and structural integrity of the compounds during storage and transit. Protide Health strictly avoids the use of unnecessary fillers in this process to ensure maximum research reliability.
Legal Disclaimer for GLP-3: The information provided in this description is for research purposes only. The GLP-3 peptide is not approved by the U.S. Food and Drug Administration (FDA) or any regulatory authority for human consumption or therapeutic use. It is intended solely for investigational use in controlled laboratory settings by qualified researchers. Consult with regulatory authorities before initiating any research involving GLP-3 peptide. Products sold by Protide Health are for laboratory research purposes only and are not intended for human consumption, medical use, or veterinary use.
GLP-3 Peptide: Triple Agonist for Preclinical Metabolic Research
The GLP-3 peptide is a synthetic, multi-receptor agonist utilized in laboratory settings to investigate incretin signaling. Researchers use these compounds to study cellular pathways related to hunger cues, glucose handling, and energy expenditure in preclinical models.
Investigating Mechanism of Action
Laboratory investigations explore how this triple-agonist structure interacts with distinct cellular receptors. Studies examine these interactions within strictly controlled environments to gather data on downstream metabolic signaling.
Triple-Receptor Activation
Preclinical models observe the simultaneous engagement of GLP-1, GIP, and glucagon receptors (PubMed). Animal studies investigate specific molecular mechanisms:
- Alterations in gastric emptying rates during controlled laboratory testing.
- Satiety (fullness) signaling pathways within neural models.
- Glucagon receptor activation and its correlation with cellular energy utilization.
Preclinical Investigational Models
The primary role of this peptide centers on modeling metabolic homeostasis and appetite regulation. Scientists utilize these compounds in animal models to yield data on complex endocrine interactions.
Energy Expenditure and Satiety Assays
Animal studies measure the compound’s influence on biological markers linked to nutrient processing. Preclinical diet-induced obesity models examine physical and metabolic shifts following exposure (PubMed). Research investigates several endpoints:
- Variations in baseline energy expenditure.
- Shifts in food intake behavior observed during laboratory trials.
- Metabolic biomarker fluctuations when comparing single versus multi-receptor agonists.
GLP-3 Specifications
| Specification | Laboratory Detail |
|---|---|
| Peptide Classification | Multi-receptor incretin agonist |
| Supplied Format | 10-50mg lyophilized powder |
| Primary Research Use | Energy-balance and metabolic models |
| Optimal Storage | Cold, dry, protected from light |
Concluding Research Considerations
The GLP-3 peptide serves as a vital instrument for investigating complex metabolic pathways and energy regulation. Preclinical studies continue to examine its unique triple-receptor agonism to understand cellular signaling.
References
- Authors. “Triple-hormone-receptor agonist in adults with obesity (phase 2).” PubMed. PubMed
- Authors. “Triple GLP-1/GIP/glucagon receptor agonist preclinical + phase 1 findings.” PubMed. PubMed
- Authors. “Incretin hormones and satiation signaling.” PMC. PubMed
Legal Disclaimer for GLP-3 Peptide
The information provided in this description is for research purposes only. The GLP-3 peptide is not approved by the U.S. Food and Drug Administration (FDA) or any regulatory authority for human consumption or therapeutic use. It is intended solely for investigational use in controlled laboratory settings by qualified researchers. Protide Health does not endorse or promote the use of GLP-3 peptide in humans or animals outside of approved research protocols. Researchers must comply with all applicable local, state, and federal regulations, including obtaining necessary approvals for experimental use. Consult with regulatory authorities before initiating any research involving GLP-3 peptide.
Products sold by Protide Health are for laboratory research purposes only and are not intended for human consumption, medical use, or veterinary use.
All GLP-3 vials are independently third-party tested and HPLC-verified at 99% purity. Certificates of Analysis (COAs) are organized by vial size below. Click any certificate to open the full-size document.
Here’s the updated code with the 40mg section inserted between 30mg and 50mg:“`html10mg — HPLC Purity Analysis & Endotoxin Report
HPLC Purity Certificate
↗ Click to enlarge
Endotoxin Report
↗ Click to enlarge
15mg — HPLC Purity Analysis
↗ Click to enlarge
20mg — HPLC Purity Analysis
↗ Click to enlarge
30mg — HPLC Purity Analysis
↗ Click to enlarge
40mg — HPLC Purity Analysis
↗ Click to enlarge
50mg — HPLC Purity Analysis
↗ Click to enlarge
| Select vial strength: | 10mg, 15mg, 20mg, 24mg, 30mg, 40mg, 50mg |
|---|
FAQs
You may also like…
-
GLP-2
Price range: $110.00 through $250.00Select options This product has multiple variants. The options may be chosen on the product page -
Tesamorelin
Price range: $85.00 through $145.00Select options This product has multiple variants. The options may be chosen on the product page -
